How to administer foscarnet?

Method of administration: Foscarnet should be administered by the intravenous route only, either by a central venous line or in a peripheral vein. When peripheral veins are used, the solution of foscarnet 24 mg/ml must be diluted.

What should I monitor with foscarnet?

For patients receiving foscarnet in an outpatient setting, serum creatinine should be monitored at least twice weekly. If creatinine increases substantially (e.g. >0.4mg/dl), consideration should be given to re-checking serum creatinine before infusion of next dose to determine if dose adjustment is necessary.

How do you dilute foscarnet?

It is recommended that 750 to 1000 mL of 0.9% sodium chloride injection or 5% dextrose solution should be given prior to the first infusion of foscarnet sodium to establish diuresis.

What is foscarnet used for?

Foscarnet is principally used for the treatment of ganciclovir-resistant cytomegalovirus (CMV) infections in patients with the acquired immunodeficiency syndrome (AIDS) or in transplant recipients.

Does foscarnet cause hypocalcemia?

Foscarnet is a drug used to treat refractory cytomegalovirus and herpes infections in patients who are immunocompromised, and it complexes ionized calcium and, therefore, lowers ionized calcium concentrations, potentially causing symptomatic hypocalcemia.

Is foscarnet antiviral?

Antiviral Agents Foscarnet also is active against HIV. This antiviral agent directly inhibits DNA polymerase by blocking the pyrophosphate binding site and preventing cleavage of pyrophosphate from deoxynucleotide triphosphates.

How is the risk of renal impairment best minimized when foscarnet is administered?

The potential for renal impairment may be minimized by accompanying FOSCAVIR administration with hydration adequate to establish and maintain a diuresis during dosing.

Does foscarnet inhibit RNA polymerase?

It inhibits DNA polymerase by blocking the pyrophosphate-binding site and preventing cleavage of pyrophosphate from deoxynucleotide triphosphates. Unlike acyclovir, which requires activation by a virus-specific TK, foscarnet acts directly on the virus DNA polymerase.

Which condition is effectively treated with famciclovir?

Famciclovir was approved by the FDA for the treatment of acute herpes zoster in 1994, and subsequently was approved for the treatment and suppression of genital HSV disease in immunocompetent patients. Famciclovir is also approved for the treatment of recurrent mucocutaneous HSV disease in HIV-infected patients.

How long does it take for foscarnet to work?

CMV infection and response to foscarnet The CI of response to foscarnet was overall 87%, with a median time to clearance of CMV of 7 days (range 1–79): response to foscarnet was significantly higher in patients grafted from HAPLO donor (84 vs 59%, p = 0.01) (Table 2, Fig.

What is the mode of action of foscarnet?

Mechanism of Action and In Vitro Activity Foscarnet blocks the pyrophosphate binding site, preventing cleavage of pyrophosphate from deoxynucleotide triphosphates. Viral DNA polymerase is inhibited at foscarnet concentrations 100-fold lower than those required to inhibit cellular DNA polymerase.

What class is foscarnet?

Foscarnet is in a class of medications called antivirals. It works by slowing the growth of CMV and HSV.

How is cidofovir excreted?

Following oral administration, the absolute bioavailability of cidofovir ranges from 5 to 22%. The primary route of elimination is renal, with approximately 90% of the total dose cleared by the kidneys. Active tubular secretion appears to play a role in the elimination of cidofovir.

What is the mechanism of action of foscarnet?

Why is famciclovir discontinued?

The reason for the discontinuation is not due to manufacturing, product quality, safety or efficacy concerns. Novartis has informed the Food and Drug Administration (FDA) of the discontinuation of Famvir (famciclovir).

Can famciclovir cause liver damage?

Famciclovir is a nucleoside analogue and antiviral agent used in therapy of herpes zoster and simplex virus infections. Famciclovir is associated with a low rate of mild-to-moderate serum ALT elevations during therapy, but has not been associated with instances of clinically apparent liver injury.

How is cidofovir administered?

The recommended dose of cidofovir is 5 mg/kg body weight (given as an intravenous infusion at a constant rate over 1 hour) administered once weekly for two consecutive weeks.

Is cidofovir cytotoxic?

Yes, cidofovir can be considered a cytotoxic medication that can harm cells, which is why it is always handled with care by healthcare professionals.

How long can you take famciclovir?

Adults—250 milligrams (mg) two times a day for up to one year. Children—Use and dose must be determined by your doctor.

Is famciclovir hard on the kidneys?

Cases of kidney failure have been reported when higher than recommended doses of famciclovir were administered to patients with underlying kidney problems.

What is the infusion rate for foscarnet?

– Infusion rate: infusion of foscarnet over <2h has been associated with symptomatic hypocalcemia (e.g. circumoral paresthesias). Initial doses should be infused over 2 hours. Reduction of infusion duration to no less than 1 hour may be attempted with careful monitoring.

How many milliliters of d5 should be given with foscarnet?

Before the initial dose, administer 750-1000ml of D5 or NS over 1 hour. With subsequent doses, administer 500-1000ml of D5 or NS concurrently with the foscarnet. In patients with fluid overload, less (but not none) hydration may be given, recognizing the associated increased risk of nephrotoxicity.

How should I administer foscarnet?

– Infusion site: Infusion through a central line is recommended when available. If infusing through a peripheral line, the solution must be diluted to £12 mg/ml. – Hydration: Ensuring adequate hydration is essential to mitigating the nephrotoxicity of foscarnet. Before the initial dose, administer 750-1000ml of D5 or NS over 1 hour.

How often should electrolytes be monitored during foscarnet therapy?

These electrolytes should be monitored 2-3 times weekly during the induction phase of foscarnet therapy (1-2 times weekly during maintenance therapy) and repleted as necessary.